Literature DB >> 31606458

Refining Risk Factors for Gastric Cancer in Patients With Lynch Syndrome to Optimize Surveillance Esophagogastroduodenoscopy.

Gautam Mankaney1, Carole Macaron2, Carol A Burke3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31606458     DOI： 10.1016/j.cgh.2019.10.003

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  5 in total

1.  Upper Endoscopic Surveillance in Lynch Syndrome Detects Gastric and Duodenal Adenocarcinomas.

Authors:  Shria Kumar; Christina M Dudzik; Mallory Reed; Jessica M Long; Kirk J Wangensteen; Bryson W Katona
Journal:  Cancer Prev Res (Phila)       Date:  2020-08-28

2.  Downregulated Expression of linc-ROR in Gastric Cancer and Its Potential Diagnostic and Prognosis Value.

Authors:  Xiuchong Yu; Haixiang Ding; Yijiu Shi; Liangwei Yang; Jiaming Zhou; Zhilong Yan; Bingxiu Xiao
Journal:  Dis Markers       Date:  2020-10-24       Impact factor: 3.434

Review 3.  Prospective observational data informs understanding and future management of Lynch syndrome: insights from the Prospective Lynch Syndrome Database (PLSD).

Authors:  Toni T Seppälä; Mev Dominguez-Valentin; Julian R Sampson; Pål Møller
Journal:  Fam Cancer       Date:  2020-06-08       Impact factor: 2.375

Review 4.  Upper Gastrointestinal Cancer Surveillance in Lynch Syndrome.

Authors:  Shria Kumar; Natalie Farha; Carol A Burke; Bryson W Katona
Journal:  Cancers (Basel)       Date:  2022-02-16       Impact factor: 6.639

Review 5.  Challenges of Neoantigen Targeting in Lynch Syndrome and Constitutional Mismatch Repair Deficiency Syndrome.

Authors:  Asima Abidi; Mark A J Gorris; Evan Brennan; Marjolijn C J Jongmans; Dilys D Weijers; Roland P Kuiper; Richarda M de Voer; Nicoline Hoogerbrugge; Gerty Schreibelt; I Jolanda M de Vries
Journal:  Cancers (Basel)       Date:  2021-05-13       Impact factor: 6.639
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.